Learn More
Apexbio Technology LLC Altiratinib 1345847-93-9 10mg

Supplier: Apexbio Technology LLC B583210
Altiratinib (DCC-2701 CAS 1345847-93-9) is a multi-targeted small molecule inhibitor designed to block the activity of the receptor tyrosine kinases c-MET TIE-2 and VEGFR It demonstrates potent inhibitory activity with reported IC50 values of 2 7 nM for c-MET 8 0 nM for TIE-2 and 9 2 nM for VEGFR In cell-based assays Altiratinib suppresses phosphorylation of MET in MET-overexpressing EBC-1 and MKN-45 cell lines and inhibits TIE2 and VEGFR2 activation in endothelial models In preclinical xenograft studies Altiratinib reduces MET phosphorylation and tumor burden This compound is utilized to investigate pathways involved in tumor growth angiogenesis and microenvironment-mediated drug resistance
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.